Michael F. Daily

Michael F. Daily

Auto-generated profile, based on publicly available information

Michael F. Daily

Division of Transplantation, Department of Surgery Dartmouth Hitchcock Medical Center Hanover New Hampshire USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in HPB
Verified
Journal Article
Closed access
PDF file
AEAlmudena Moreno Elola-Olaso
Almudena Moreno Elola-Olaso
DDDaniel L. Davenport
Daniel L. Davenport
JHJonathan C. Hundley
Jonathan C. Hundley
MDMichael F. Daily
Michael F. Daily
RGRoberto Gedaly
Roberto Gedaly

1 December 2010
Verified
Journal Article
Closed access
RGRoberto Gedaly
Roberto Gedaly
PAPaul Angulo
Paul Angulo
JHJonathan Hundley
Jonathan Hundley
MDMichael F Daily
Michael F Daily
CCChangguo Chen
Changguo Chen
BEB Mark Evers
B Mark Evers

1 August 2012 in Journal of Surgical Research
Verified
Journal Article
Closed access
RGRoberto Gedaly
Roberto Gedaly
PAPaul Angulo
Paul Angulo
JHJonathan Hundley
Jonathan Hundley
MDMichael F. Daily
Michael F. Daily
CCChangguo Chen
Changguo Chen
BEB. Mark Evers
B. Mark Evers

19 January 2016 in Liver International
Verified
Journal Article
Closed access
PDF file
CCCristin Coquillard
Cristin Coquillard
JBJonathan Berger
Jonathan Berger
MDMichael Daily
Michael Daily
MSMalay Shah
Malay Shah
XMXiaonan Mei
Xiaonan Mei
RGRoberto Gedaly
Roberto Gedaly

1 April 2015 in JAMA Surgery
Verified
Journal Article
Closed access
PDF file
SASayee Sundar Alagusundaramoorthy
Sayee Sundar Alagusundaramoorthy
VVValery Vilchez
Valery Vilchez
AZAnthony Zanni
Anthony Zanni
ASAchuthan Sourianarayanane
Achuthan Sourianarayanane
EMErin Maynard
Erin Maynard
RGRoberto Gedaly
Roberto Gedaly
Research from JAMA Surgery — Role of Transplantation in the Treatment of Benign Solid Tumors of the Liver — A Review of the United Network of Organ Sharing Data Set

15 April 2010 in Transplantation
Verified
Journal Article
Closed access
CTChristoph Troppmann
Christoph Troppmann
MDMichael F. Daily
Michael F. Daily
JMJohn P. McVicar
John P. McVicar
KTKathrin M. Troppmann
Kathrin M. Troppmann
RPRichard V. Perez
Richard V. Perez
Retroperitoneoscopic live donor nephrectomy (RetroNeph) offers an intrinsic advantage over conventional transperitoneal laparoscopic nephrectomy (LapNeph) because of the potentially lower risk for early and late intraperitoneal donor complications. RetroNeph, however, is infrequently performed and has not been systematically and directly compared with LapNeph in nonselected donors. In November 2007, after 10 years of programmatic experience with transperitoneal LapNeph, we implemented RetroNeph at once for all live donor nephrectomies. Donor selection criteria, laparoscopic port positions, and hand-assistance mode were identical for RetroNeph and preceding LapNeph donors. We compared outcomes of retroperitoneoscopically completed cases with those of previous transperitoneal LapNeph cases that were pair matched for donor sex, body mass index, and donor kidney laterality. Of the first 52 donor nephrectomies (48 left, 4 right) consecutively started with the intent to perform a RetroNeph November 2007 to April 2009, 45 (87%) were completed retroperitoneoscopically, and seven (13%) were switched intraoperatively to transperitoneal LapNeph. We observed no conversions to open nephrectomy, donor blood transfusions, readmissions, or reoperations. Matched-pair analysis of the 45 RetroNeph versus 45 LapNeph cases showed no significant differences for warm ischemia time and other donor outcomes, delayed graft function rates, recipient creatinine at 1 week, and 1-year graft survival. Implementation of a RetroNeph program had no adverse impact on donor morbidity and quality of early graft function. Our pilot experience suggests that the RetroNeph learning curve is short. Given the potential advantages of an extraperitoneal approach for the donor, RetroNeph is an attractive alternative to LapNeph, particularly for surgeons with previous LapNeph experience.